These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

462 related articles for article (PubMed ID: 17684761)

  • 1. Site-specific biology and pathology of gastroenteropancreatic neuroendocrine tumors.
    Klöppel G; Rindi G; Anlauf M; Perren A; Komminoth P
    Virchows Arch; 2007 Aug; 451 Suppl 1():S9-27. PubMed ID: 17684761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Classification and pathology of gastroenteropancreatic neuroendocrine neoplasms.
    Klöppel G
    Endocr Relat Cancer; 2011 Oct; 18 Suppl 1():S1-16. PubMed ID: 22005112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Trends in gastroenteropancreatic neuroendocrine tumors].
    Kajiwara H; Osamura Y
    Nihon Geka Gakkai Zasshi; 2008 May; 109(3):123-7. PubMed ID: 18536314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lung and digestive neuroendocrine neoplasms. From WHO classification to biomarker screening: Which perspectives?
    Scoazec JY
    Ann Endocrinol (Paris); 2019 Jun; 80(3):163-165. PubMed ID: 31064659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of World Health Organization 2000/2004 and World Health Organization 2010 classifications for gastrointestinal and pancreatic neuroendocrine tumors.
    Pasaoglu E; Dursun N; Ozyalvacli G; Hacihasanoglu E; Behzatoglu K; Calay O
    Ann Diagn Pathol; 2015 Apr; 19(2):81-7. PubMed ID: 25702616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and clinical characteristics of gastroenteropancreatic neuroendocrine tumor in Korea: a single-center experience.
    Lim CH; Lee IS; Jun BY; Kim JS; Cho YK; Park JM; Roh SY; Lee MA; Kim SW; Choi MG
    Korean J Intern Med; 2017 May; 32(3):452-458. PubMed ID: 28490723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of nuclear p27 expression and its prognostic role in relation to cyclin E and p53 mutation in gastroenteropancreatic neuroendocrine tumors.
    Grabowski P; Schrader J; Wagner J; Hörsch D; Arnold R; Arnold CN; Georgieva I; Stein H; Zeitz M; Daniel PT; Sturm I
    Clin Cancer Res; 2008 Nov; 14(22):7378-84. PubMed ID: 19010853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aspects regarding nomenclature, classification and pathology of neuroendocrine neoplasms of the digestive system - a review.
    Păun I; Becheanu G; Costin AI; Constantin VD; Mihai GM; Radu L; Iovan L; Vârcuş F
    Rom J Morphol Embryol; 2018; 59(3):673-678. PubMed ID: 30534804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Digestive neuroendocrine tumors: reclassifying of 26 cases according to 2010 who classification.
    Chaabane A; M'sakni I; Laabidi B; Bougrine F; Bouziani A
    Tunis Med; 2016 Oct; 94(8-9):580-586. PubMed ID: 28685792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastroenteropancreatic neuroendocrine tumours: the current incidence and staging based on the WHO and European Neuroendocrine Tumour Society classification: an analysis based on prospectively collected parameters.
    Niederle MB; Hackl M; Kaserer K; Niederle B
    Endocr Relat Cancer; 2010 Dec; 17(4):909-18. PubMed ID: 20702725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic relevance of a novel TNM classification system for upper gastroenteropancreatic neuroendocrine tumors.
    Pape UF; Jann H; Müller-Nordhorn J; Bockelbrink A; Berndt U; Willich SN; Koch M; Röcken C; Rindi G; Wiedenmann B
    Cancer; 2008 Jul; 113(2):256-65. PubMed ID: 18506737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Neuroendocrine tumors of digestive system: morphologic spectrum and cell proliferation (Ki67 index)].
    Delektorskaia VV; Kushliskiĭ NE
    Vestn Ross Akad Med Nauk; 2013; (5):28-37. PubMed ID: 24000665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Neuroendocrine tumours of the alimentary tract--history and at present].
    Mandys V
    Cesk Patol; 2009 Jul; 45(3):57-63. PubMed ID: 19764158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastroenteropancreatic Well-Differentiated Grade 3 Neuroendocrine Tumors: Review and Position Statement.
    Coriat R; Walter T; Terris B; Couvelard A; Ruszniewski P
    Oncologist; 2016 Oct; 21(10):1191-1199. PubMed ID: 27401895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of CD133 in neuroendocrine neoplasms of the digestive tract: a detailed immunohistochemical analysis.
    Mia-Jan K; Munkhdelger J; Lee MR; Ji SY; Kang TY; Choi E; Cho MY
    Tohoku J Exp Med; 2013 Apr; 229(4):301-9. PubMed ID: 23615455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Classification of gastro-entero-pancreatic neuroendocrine tumors].
    Perren A; Schmitt A; Komminoth P; Pavel M
    Radiologe; 2009 Mar; 49(3):198-205. PubMed ID: 19224191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pathology of neuroendocrine neoplasms].
    Anlauf M; Gerlach P; Schott M; Raffel A; Krausch M; Knoefel WT; Pavel M; Klöppel G
    Chirurg; 2011 Jul; 82(7):567-73. PubMed ID: 21487814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastroenteropancreatic (neuro)endocrine neoplasms: the histology report.
    Rindi G; Bordi C; La Rosa S; Solcia E; Delle Fave G; ;
    Dig Liver Dis; 2011 Mar; 43 Suppl 4():S356-60. PubMed ID: 21459341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endocrine tumors of the gut and pancreas tumor biology and classification.
    Rindi G; Klöppel G
    Neuroendocrinology; 2004; 80 Suppl 1():12-5. PubMed ID: 15477709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Problem of High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms: Well-Differentiated Neuroendocrine Tumors, Neuroendocrine Carcinomas, and Beyond.
    Sorbye H; Baudin E; Perren A
    Endocrinol Metab Clin North Am; 2018 Sep; 47(3):683-698. PubMed ID: 30098724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.